Bio 3D printing materials company COLLPLANT completes US$5.5 million financing

China3D printingNet news on September 24,biology3D printingMachine materials developer CollPlant (NASDAQ: CLGN) has confirmed receipt of USD 5.5 millioninvest.The transaction is made up of a group of pairs3D printingProvided by Ami Sagi, a particularly interested investor in the industry and the company’s largest shareholder, the transaction was confirmed on September 9, 2019. The anonymous investor group provided $3.5 million in convertible loans, while the remaining $2 million was purchased by Sagi through a non-broker private placement. After signing licenses and/or co-development agreements with strategic business partners, Sagi will also provide an additional $1 million in investment.

CollPlant CEO Yehiel Tal commented: “The fundraising aims to support our medical aesthetics and tissue and organ development.3D bioprintingThe development of product lines in the field. “” […]We are very happy to have this transaction with Mr. Sagi and other investors. “

Yehiel Tal, CEO of CollPlant. Photo: Globes.co

CollPlant biology3D printing

CollPlant is mainly a regenerative medicine company, and its proprietary development product is rhCollagen (recombinant human collagen) products. rhCollagen is a 3D printable bio-ink, which can be used as a support material for biological substances (ie, human stem cells). It is plant-based and harvested from genetically modified tobacco plants.
Although the application of this material is still in its infancy, it may be far from being able to provide a fully functional3D printingOrgans will take some time, but many of CollPlant’s projects demonstrate the company’s ambitions.

In October 2018, United Therapeutics Corporation, a biotechnology company headquartered in Maryland, signed a license agreement with CollPlant to use its bioink technology for3D bioprintingDevelopment of the lung model.Inside the company, the company is currently testing its3D bioprintingTechnology as a viable option for breast implants. According to Tal, the company is also currently “focused on promoting our dermal filler development program”.



CollPlant rhCollagen bio-ink. Picture from CollPlant

About investors

Most investors in CollPlant’s latest round of investment chose to remain anonymous, and CollPlant seems to be the main investment in Sagi’s current investor profile. According to the terms of the agreement with CollPlant, all parties will obtain three-year warrants to purchase a total of 1,625,000 shares of ADS at a price of US$4.00 each.

China3D printingNet original article!

(Editor in charge: admin)